203 related articles for article (PubMed ID: 28059092)
21. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.
Murayama S; Akiyama M; Namba H; Wada Y; Ida H; Kunishima S
Pediatr Int; 2013 Feb; 55(1):102-4. PubMed ID: 23409987
[TBL] [Abstract][Full Text] [Related]
22. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and natural history of variants in the
Vyas H; Alcheikh A; Lowe G; Stevenson WS; Morgan NV; Rabbolini DJ
Platelets; 2022 Nov; 33(8):1107-1112. PubMed ID: 35587581
[No Abstract] [Full Text] [Related]
24. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.
Letestu R; Vitrat N; Massé A; Le Couedic JP; Lazar V; Rameau P; Wendling F; Vuillier J; Boutard P; Plouvier E; Plasse M; Favier R; Vainchenker W; Debili N
Blood; 2000 Mar; 95(5):1633-41. PubMed ID: 10688818
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia in a child with hereditary thrombocytopenia.
Rheingold SR
Pediatr Blood Cancer; 2007 Jan; 48(1):105-7. PubMed ID: 16276527
[TBL] [Abstract][Full Text] [Related]
26. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53.
Kanagal-Shamanna R; Bueso-Ramos CE; Barkoh B; Lu G; Wang S; Garcia-Manero G; Vadhan-Raj S; Hoehn D; Medeiros LJ; Yin CC
Cancer; 2012 Jun; 118(11):2879-88. PubMed ID: 22038701
[TBL] [Abstract][Full Text] [Related]
27. International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing country.
Glembotsky AC; Marta RF; Pecci A; De Rocco D; Gnan C; Espasandin YR; Goette NP; Negro F; Noris P; Savoia A; Balduini CL; Molinas FC; Heller PG
J Thromb Haemost; 2012 Aug; 10(8):1653-61. PubMed ID: 22672365
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of MYH9 expression on patients with acute myeloid leukemia.
Yu M; Wang J; Zhu Z; Hu C; Ma Q; Li X; Yin X; Huang J; Zhang T; Ma Z; Zhou Y; Li C; Chen F; Chen J; Wang Y; Pan H; Wang D; Jin J
Oncotarget; 2017 Jan; 8(1):156-163. PubMed ID: 27437869
[TBL] [Abstract][Full Text] [Related]
29. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.
Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A
Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073
[TBL] [Abstract][Full Text] [Related]
30. Acute myeloid leukemia in a patient with thrombocytopenia with absent radii: A case report and review of the literature.
Jameson-Lee M; Chen K; Ritchie E; Shore T; Al-Khattab O; Gergis U
Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):245-247. PubMed ID: 28259746
[TBL] [Abstract][Full Text] [Related]
31. A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23.
Breton-Gorius J; Favier R; Guichard J; Cherif D; Berger R; Debili N; Vainchenker W; Douay L
Blood; 1995 Apr; 85(7):1805-14. PubMed ID: 7703487
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.
Wang SA; Hasserjian RP; Tam W; Tsai AG; Geyer JT; George TI; Foucar K; Rogers HJ; Hsi ED; Rea BA; Bagg A; Bueso-Ramos CE; Arber DA; Verstovsek S; Orazi A
Haematologica; 2017 Aug; 102(8):1352-1360. PubMed ID: 28495918
[TBL] [Abstract][Full Text] [Related]
33. Hypoplastic myelodysplastic syndrome.
Nand S; Godwin JE
Cancer; 1988 Sep; 62(5):958-64. PubMed ID: 3409176
[TBL] [Abstract][Full Text] [Related]
34. [Clinical features and MYH9 gene variant in two Chinese siblings with Fechtner syndrome].
Zhao SL; Zhao F; Zhang AH; Huang SM
Zhonghua Er Ke Za Zhi; 2019 Apr; 57(4):286-290. PubMed ID: 30934202
[No Abstract] [Full Text] [Related]
35. Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up.
Ghanima W; Geyer JT; Lee CS; Boiocchi L; Imahiyerobo AA; Orazi A; Bussel JB
Haematologica; 2014 May; 99(5):937-44. PubMed ID: 24463212
[TBL] [Abstract][Full Text] [Related]
36. Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells.
Pecci A; Bozzi V; Panza E; Barozzi S; Gruppi C; Seri M; Balduini CL
Thromb Haemost; 2011 Oct; 106(4):693-704. PubMed ID: 21833445
[TBL] [Abstract][Full Text] [Related]
37. A De Novo Mutation in MYH9 in a Child With Severe and Prolonged Macrothrombocytopenia.
Li K; Jin R; Xu W; Shen Y; Lu K; Wu X
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e7-e10. PubMed ID: 32520844
[TBL] [Abstract][Full Text] [Related]
38. Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia.
Parker RI; Siegel RS; Ratajczak MZ; Gewirtz AM
J Pediatr Hematol Oncol; 1998; 20(3):196-201. PubMed ID: 9628429
[TBL] [Abstract][Full Text] [Related]
39. Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia.
Melazzini F; Palombo F; Balduini A; De Rocco D; Marconi C; Noris P; Gnan C; Pippucci T; Bozzi V; Faleschini M; Barozzi S; Doubek M; Di Buduo CA; Kozubik KS; Radova L; Loffredo G; Pospisilova S; Alfano C; Seri M; Balduini CL; Pecci A; Savoia A
Haematologica; 2016 Nov; 101(11):1333-1342. PubMed ID: 27365488
[TBL] [Abstract][Full Text] [Related]
40. Pediatric hyperfibrotic myelodysplasia: an unusual clinicopathologic entity.
Sahu S; Shah SS; Srivastava A; Dennison D; Chandy M
Pediatr Hematol Oncol; 1997; 14(2):133-9. PubMed ID: 9089741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
